New Boron and Gadolinium Agents for Neutron Capture Therapy

用于中子捕获治疗的新型硼和钆剂

• 批准号: DP0986055
• 负责人: Prof Louis Rendina
• 金额: $ 28.36万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-07-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0986055
• 关键词: New; Boron; Gadolinium; Agents; Neutron

The development of new drugs and treatments for cancer is highly important for improved health outcomes and the well-being of the community. This research has the potential to result in the development of new anticancer pharmaceuticals that will dramatically expand the clinical efficacy of a promising treatment for highly aggressive tumours. The innovative nature of this research will also contribute to Australia's science knowledge base, a key element in its future economic prosperity, and it will provide excellent training of young researchers for employment in the rapidly expanding field of drug design and development.

癌症新药和治疗方法的开发对于改善健康结果和社区福祉非常重要。 这项研究有可能导致新的抗癌药物的开发，这将大大扩大一个有前途的治疗高度侵袭性肿瘤的临床疗效。 这项研究的创新性质也将有助于澳大利亚的科学知识基础，这是其未来经济繁荣的一个关键因素，它将为年轻研究人员在迅速扩大的药物设计和开发领域的就业提供良好的培训。